Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients

BACKGROUND: Neoadjuvant chemotherapy (NAC) has become the standard therapeutic option for early high-risk and locally advanced breast cancer. However, response rates to NAC vary between patients, causing delays in treatment and affecting the prognosis for patients who do not sensitive to NAC. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jieqiu, Wu, Qi, Yin, Wei, Yang, Lu, Xiao, Bo, Wang, Jianmei, Yao, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176880/
https://www.ncbi.nlm.nih.gov/pubmed/37173635
http://dx.doi.org/10.1186/s12885-023-10817-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176880/
https://www.ncbi.nlm.nih.gov/pubmed/37173635
http://dx.doi.org/10.1186/s12885-023-10817-2

Ejemplares similares